InvestorsHub Logo

amarinbullfromchicago

03/29/19 3:38 PM

#184461 RE: KevGee59 #184459

Awesome! sign of things to come

stoneroad

03/29/19 3:39 PM

#184462 RE: KevGee59 #184459

Going to be hard for FDA not to give PR.

dmlcento

03/29/19 3:44 PM

#184467 RE: KevGee59 #184459

Great news. How about a priority review over in China.

biowreck

03/29/19 3:44 PM

#184468 RE: KevGee59 #184459

Canadian healthcare...gotta love it....hope the FDA takes notice! Corrupt slime heads.......

MNBioMike

03/29/19 3:44 PM

#184469 RE: KevGee59 #184459

Yahoo Buckaroo!

Whalatane

03/29/19 3:51 PM

#184475 RE: KevGee59 #184459

Kev. great find
thx
Kiwi

NickHous

03/29/19 3:51 PM

#184476 RE: KevGee59 #184459

Wow! Thanks KG, let's see if FDA follows Canada with Priority Review. Don't see why not! Oh man!!!!!

studythosestocks

03/29/19 3:51 PM

#184477 RE: KevGee59 #184459

This is awesome news! Wow, things just keep falling into place. What a great time to be watching this paradigm shift in action! Agreed. WS doesn’t know yet I don’t think.

KCSVEN

03/29/19 3:56 PM

#184480 RE: KevGee59 #184459

That's fast because they must have just submitted it:

"In Canada, Amarin and its newest partner HLS Therapeutics are hopeful that REDUCE-IT results will support efforts to gain regulatory approval to commercialize Vascepa although, similar to the pathway in the U.S., the REDUCE-IT data package is still being prepared and regulatory submission in Canada cannot be made until after that data package is ready for submission in the U.S."